Andrei V Krivstov

Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting

Jie He, Omar Abdel‐Wahab, Michelle Nahas et al. · Blood · 2016 · 309 citations · Full text

Medicine, Hematology, Oncology +16

Final Report of Phase 1 Study of the DOT1L Inhibitor, Pinometostat (EPZ-5676), in Children with Relapsed or Refractory MLL-r Acute Leukemia

Neerav Shukla, Cynthia Wetmore, Maureen M. O’Brien et al. · Blood · 2016 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +13

A Phase 1 Study of the DOT1L Inhibitor, Pinometostat (EPZ-5676), in Adults with Relapsed or Refractory Leukemia: Safety, Clinical Activity, Exposure and Target Inhibition

Eytan M. Stein, Guillermo Garcia‐Manero, David A. Rizzieri et al. · Blood · 2015 · 48 citations

Medicine, Oncology, Pharmacology +13

Preliminary Report of the Phase 1 Study of the DOT1L Inhibitor, Pinometostat, EPZ-5676, in Children with Relapsed or Refractory MLL-r Acute Leukemia: Safety, Exposure and Target Inhibition

Neerav Shukla, Maureen M. O’Brien, Lewis B. Silverman et al. · Blood · 2015 · 13 citations

Medicine, Oncology, Pharmacology +15